Reversible sulfasalazine-induced granulomatous hepatitis.
Sulfasalazine, a drug common in the treatment of inflammatory bowel disease, may cause liver damage. We present a patient with documented granulomatous hepatitis which resolved on liver biopsy 6 weeks after discontinuation of the drug.
D000328:Adult; D056486:Chemical and Drug Induced Liver Injury; D006099:Granuloma / Q000139:chemically induced* / Q000473:pathology; D006505:Hepatitis / Q000209:etiology* / Q000473:pathology; D006801:Humans; D008107:Liver Diseases / Q000473:pathology; D008297:Male; D012460:Sulfasalazine / Q000009:adverse effects*
D012460:Sulfasalazine